Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Acinic cell carcinoma diagnostic study of choice
Introduction
Overview
Overview
The presence of tumor in parotid gland is first detected by its symptoms and then its consistency is further analysed by CT-scan. Recurrent abnormality of cytogenetic t(12;15) ETV6-NRTK3 is the gold standard test for the diagnosis of acinic cell carcinoma.
Diagnostic Study of Choice
Diagnostic Study of Choice
Study of choice
- The presence of tumor in parotid gland is first detected by its symptoms and then its consistency is further analysed by CT-scan. [1]
- Recurrent abnormality of cytogenetic t(12;15) ETV6-NRTK3 is the gold standard test for the diagnosis of acinic cell carcinoma.[2]
References
References
- ↑ Bussu F, Parrilla C, Rizzo D, Almadori G, Paludetti G, Galli J (2011). “Clinical approach and treatment of benign and malignant parotid masses, personal experience”. Acta Otorhinolaryngol Ital. 31 (3): 135–43. PMC 3185824. PMID 22058591.
- ↑ Ripamonti, Carla B; Colombo, Mara; Mondini, Patrizia; Siranoush, Manoukian; Peissel, Bernard; Bernard, Loris; Radice, Paolo; Carcangiu, Maria Luisa (2013). “First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report”. BMC Cancer. 13 (1). doi:10.1186/1471-2407-13-46. ISSN 1471-2407.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]